Search for clinical trials.
A Focus On Science
NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.
Our Mission
Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research
Dr. Robert S. Mannel
Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.
Membership Resources
NRG Oncology’s membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.
Learn MoreLatest News
NRG seeks to fill Translational Science Committee Vice Chair Positions (Gynecologic, Radiation Oncology)
NRG Oncology seeks to fill the position of Chair, NRG Oncology Pharmacy Subcommittee
Practice-Defining NRG Oncology Trial Finds Chemotherapy Followed by Letrozole is the Standard for Advanced, Low Grade Serous Gynecologic Carcinoma
Stay current with science. Sign up for our newsletter.
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More